|
2025 Journal Article Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver diseaseGracen, Lucy, Hartel, Gunter, Irvine, Katharine M., Aikebuse, Melanie, Valery, Patricia C. and Powell, Elizabeth E. (2025). Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver disease. Clinical Gastroenterology and Hepatology, 23 (5), 874-876. doi: 10.1016/j.cgh.2024.09.014 |
|
2025 Journal Article Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)Allen, Michelle J., Tulleners, Ruth, Brain, David, O’Beirne, James, Powell, Elizabeth E., Barnett, Adrian, Valery, Patricia C., Kularatna, Sanjeewa and Hickman, Ingrid J. (2025). Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial). BMC Health Services Research, 25 (1) 421, 1-13. doi: 10.1186/s12913-025-12580-5 |
|
2025 Journal Article A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final surveySenanayake, Sameera, Barnett, Adrian, Brain, David, Allen, Michelle, Powell, Elizabeth E., O’Beirne, James, Valery, Patricia, Hickman, Ingrid J. and Kularatna, Sanjeewa (2025). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final survey. F1000Research, 14 96, 1-17. doi: 10.12688/f1000research.157017.1 |
|
2025 Journal Article High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLDPowell, Elizabeth E., Hartel, Gunter, Irvine, Katharine M., O’Beirne, James, Bhasker, Vikas and Valery, Patricia C. (2025). High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLD. Gastro Hep Advances, 4 (4) 100607, 1-3. doi: 10.1016/j.gastha.2024.100607 |
|
2024 Journal Article Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLDTulleners, Ruth, Barnett, Adrian, O'Beirne, James, Powell, Elizabeth, Hickman, Ingrid J., Valery, Patricia C., Kularatna, Sanjeewa, Stuart, Katherine, McIvor, Carolyn, Witness, Elen, Aikebuse, Melanie and Brain, David (2024). Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD. BMJ Open Gastroenterology, 11 (1) e001418, e001418. doi: 10.1136/bmjgast-2024-001418 |
|
2024 Journal Article A new treatment and updated clinical practice guidelines for MASLDPowell, Elizabeth E. (2024). A new treatment and updated clinical practice guidelines for MASLD. Nature Reviews Gastroenterology and Hepatology, 22 (2), 88-89. doi: 10.1038/s41575-024-01014-y |
|
2024 Journal Article An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerationsGracen, Lucy, Aikebuse, Melanie, Sarraf, Babak, McPhail, Steven, Russell, Anthony, O’Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerations. Patient Preference and Adherence, Volume 18, 1845-1855. doi: 10.2147/ppa.s468705 |
|
2024 Journal Article Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage studySarraf, B., Skoien, R., Hartel, G., O'Beirne, J., Clark, P. J., Collins, L., Leggett, B., Powell, E. E. and Valery, P. C. (2024). Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study. Public Health, 232, 178-187. doi: 10.1016/j.puhe.2024.04.030 |
|
2024 Journal Article Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancerPowell, Elizabeth E., Roche, Shruti, Sarraf, Babak, Hartel, Gunter, Skoien, Richard, Leggett, Barbara, O'Beirne, James and Valery, Patricia C. (2024). Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer. JGH Open, 8 (7) e70000, e70000. doi: 10.1002/jgh3.70000 |
|
2024 Journal Article High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in AustraliaValery, Patricia C., Roche, Shruti, Brown, Catherine, O’Beirne, James, Hartel, Gunter, Leggett, Barbara, Skoien, Richard and Powell, Elizabeth E. (2024). High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia. International Journal for Equity in Health, 23 (1) 84, 1-11. doi: 10.1186/s12939-024-02153-z |
|
2024 Journal Article A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, AustraliaSenanayake, S., Barnett, A., Brain, D., Allen, M., Powell, E.E., O'Beirne, J., Valery, P., Hickman, I.J. and Kularatna, S. (2024). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia. Public Health, 228, 105-111. doi: 10.1016/j.puhe.2024.01.007 |
|
2024 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Narro, Graciela E. Castro, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2024). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology, 29 (1) 101133, 101133. doi: 10.1016/j.aohep.2023.101133 |
|
2023 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Pablo Arab, Juan, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78 (6), 1966-1986. doi: 10.1097/HEP.0000000000000520 |
|
2023 Journal Article Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsGracen, Lucy, Muthukumara, Withma, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine M., Williams, Suzanne, Puri, Gaurav, Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2023). Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of Hepatology, 28 (6) 101142, 101142. doi: 10.1016/j.aohep.2023.101142 |
|
2023 Journal Article Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeuticsHuang, Gary, Wallace, Daniel F., Powell, Elizabeth E., Rahman, Tony, Clark, Paul J. and Subramaniam, V. Nathan (2023). Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeutics. Biomedicines, 11 (10) 2809, 1-15. doi: 10.3390/biomedicines11102809 |
|
2023 Journal Article Changing prevalence of medication use in people with cirrhosis: a retrospective cohort study using pharmaceutical benefits scheme dataHayward, Kelly L., Weersink, Rianne A., Bernardes, Christina M., McIvor, Carolyn, Rahman, Tony, Skoien, Richard, Clark, Paul J., Stuart, Katherine A., Hartel, Gunter, Valery, Patricia C. and Powell, Elizabeth E. (2023). Changing prevalence of medication use in people with cirrhosis: a retrospective cohort study using pharmaceutical benefits scheme data. Drugs - Real World Outcomes, 10 (4), 605-618. doi: 10.1007/s40801-023-00390-2 |
|
2023 Journal Article Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort studyO'Beirne, James, Skoien, Richard, Leggett, Barbara A., Hartel, Gunter F., Gordon, Louisa G., Powell, Elizabeth E. and Valery, Patricia C. (2023). Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia, 219 (8), 358-365. doi: 10.5694/mja2.52104 |
|
2023 Journal Article A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsAllen, Michelle J, Doran, Rachael, Brain, David, Powell, Elizabeth E, O’Beirne, James, Valery, Patricia C, Barnett, Adrian, Hettiarachchi, Ruvini, Hickman, Ingrid J and Kularatna, Sanjeewa (2023). A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research, 23 (1) 950, 1-12. doi: 10.1186/s12913-023-09934-2 |
|
2023 Journal Article Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?Valery, Patricia C. and Powell, Elizabeth E. (2023). Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?. The Lancet Gastroenterology and Hepatology, 8 (8), 684-685. doi: 10.1016/s2468-1253(23)00149-8 |
|
2023 Journal Article Social networks and citizenship behavior: the mediating effect of organizational identificationZagenczyk, Thomas J. and Powell, E. Erin (2023). Social networks and citizenship behavior: the mediating effect of organizational identification. Human Resource Management, 62 (4), 461-475. doi: 10.1002/hrm.22144 |
